We are live on
!
Find out more
BC
Bruce & Co Portfolio holdings
AUM
$350M
1-Year Est. Return
33.5%
This Fund
S&P 500
This Quarter
Est. Return
-3.62%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$367M
AUM Growth
-$21M
(-5.4%)
Cap. Flow
-$20.3M
Cap. Flow
% of AUM
-5.53%
Top 10 Holdings %
Top 10 Hldgs %
70.94%
Holding
38
New
2
Increased
6
Reduced
17
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kodiak Sciences
KOD
|
+$3.31M |
| 2 |
Insteel Industries
IIIN
|
+$2.02M |
| 3 |
LVTX
LAVA Therapeutics
LVTX
|
+$1.6M |
| 4 |
Fate Therapeutics
FATE
|
+$863K |
| 5 |
Caribou Biosciences
CRBU
|
+$623K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
|
+$2.3M |
| 2 |
AbbVie
ABBV
|
+$1.64M |
| 3 |
Allstate
ALL
|
+$1.45M |
| 4 |
U-Haul Holding Co Series N
UHAL.B
|
+$1.13M |
| 5 |
Supernus Pharmaceuticals
SUPN
|
+$385K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.88% |
| 2 | Utilities | 30.27% |
| 3 | Industrials | 12.87% |
| 4 | Communication Services | 6.7% |
| 5 | Financials | 5.13% |
Similar funds
RFS
WMP
PCM
SA
MC
KFG
LAS
GAA
Bruce & Co's Q1 2023 Portfolio in Review
As of Q1 2023, Bruce & Co held 38 positions worth $367M, down 5.4% from $388M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Bruce & Co withdrew a net $20.3M in Q1 2023, closing 1 position and reducing 17 holdings. Its most notable exit was Amryt Pharma plc American Depositary Shares, an estimated $2.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 36% a quarter earlier, followed by Utilities and Industrials.
Against the trend, Bruce & Co opened a new position in Kodiak Sciences worth $2.93M.
- Bruce & Co's largest Q1 2023 buy was Kodiak Sciences: 473,000 shares worth $2.93M.
- Bruce & Co added most to Insteel Industries in Q1 2023, an estimated $2.02M increase.
- Bruce & Co's biggest Q1 2023 reduction was AbbVie, cutting an estimated $1.64M.
- Bruce & Co fully exited Amryt Pharma plc American Depositary Shares in Q1 2023, selling an estimated $2.3M.
- Bruce & Co's ten largest holdings make up 71% of its $367M portfolio in Q1 2023.
- Bruce & Co opened 2 new positions and closed 1 in Q1 2023.
- Bruce & Co's portfolio value fell 5.4% quarter-over-quarter to $367M.
Based on Bruce & Co's 13F filing for Q1 2023, filed 12 May 2023.